2 min read
A groundbreaking clinical trial has demonstrated that a custom-designed mRNA vaccine developed by Merck and Moderna substantially lowers the likelihood...
Moderna
1 min read
Merck and Moderna revealed Wednesday that their investigational personalized mRNA cancer vaccine demonstrated efficacy in a substantial phase 3 clinical...
2 min read
The Food and Drug Administration has cleared mFlusiva, a groundbreaking influenza vaccine developed by Moderna using mRNA technology, marking the...
